Page Components

Why every heart mATTRs

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially life-threatening condition that affects the heart and is associated with heart failure. Early detection and prompt management of ATTR-CM is essential to optimise the prognosis of people with this condition.1

Every Heart mATTRs exists to provide healthcare professionals and people who may be living with ATTR-CM with the information and resources to help identify this potentially fatal condition that has been living in the shadows of heart failure.

  1. Witteles RM et al. JACC Heart Fail 2019;7(8):709–16.